Navigation Links
Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease

day dose-range based on UPDRS scoring.

The cognition component of the trial was a secondary endpoint and was carried out in selected centers, equipped to perform this type of assessment.
2 Strategic Target Detection Test (complex attention, executive function): This test requires the subject to touch the target stimuli (shapes) directly of a touch screen. The participant must learn which target is correct by choosing one of the stimuli following computer-generated feedback.
3 Auditory Number Sequencing (attention, working memory, executive function): Subjects hear a series of numbers (e.g. “9.. 3.. 6“; minimum=2 digits, maximum=8 digits) and are asked to repeat the numbers in order, from lowest to highest, requiring both working memory maintenance and manipulation.

About safinamide
Safinamide is an alpha-aminoamide derivative which is orally administered. Safinamide is believed to have a novel mode of action as a dopamine modulator (comprising both selective and reversible MAO-B inhibition and also blockade of dopamine reuptake) complemented by an effect on the glutamate pathway. Studies suggest that safinamide may combine the inhibition of dopamine re-uptake and MAO-B, two key mechanisms involved in the control of dopamine concentration in the brain, and inhibition of glutamate release. If regulatory approvals are obtained, Merck Serono and Newron believe that safinamide, as an adjunctive treatment to dopamine agonists and levodopa, may have a competitive advantage over current therapies for Parkinson’s disease.

About Parkinson’s disease
Parkinson's disease is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills and speech. Parkinson's disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia) and, in extreme cases, a loss of physi
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
5. Antisense Pharma: Promising Phase IIb Results of Targeted Therapy with AP 12009 in Recurrent Anaplastic Astrocytoma
6. Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia
7. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
8. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
9. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
10. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
11. Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer
Post Your Comments:
(Date:8/19/2014)... LOUIS , Aug. 19, 2014  Sequence, Inc., an ... for pharmaceutical, biotech and medical device manufacturers is opening a ... St. Louis , as a result of demand ... new location, which opened this month, allows Sequence to better ... Establishing a St. Louis office provides ...
(Date:8/19/2014)... MENLO PARK, Calif. , Aug. 19, 2014 /PRNewswire/ ... announced today a protocol amendment to allow for expanded dosing ... U.S. Food and Drug Administration (FDA) and that a new ... at three clinical trial sites in the United ... of US$2.9 million have been raised through warrant exercise in ...
(Date:8/19/2014)... , August 19, 2014 According ... Market (Neurosurgical Navigation Systems, ENT Navigation Systems and ... Growth, Trends and Forecast, 2014 - 2020", the global ... million in 2013 and is expected to grow at ... reach an estimated value of USD 295.5 million in ...
Breaking Medicine Technology:Quality and Compliance Solutions Provider Announces Opening of St. Louis, Missouri Office 2DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 2DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 4DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 5DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 6DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 2Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 4Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 5Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 6Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 8Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 9
... BEIJING, Nov. 9, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ... biopharmaceutical products in China, announced today the positive top-line ... proprietary inactivated vaccine against human enterovirus 71 (EV71), which ... Phase II results for the EV71 vaccine showed a ...
... HARBIN, China, Nov. 9, 2011 /PRNewswire-Asia/ -- China Sky One ... CSKI ), a leading fully integrated pharmaceutical company producing ... announced financial results for the third quarter of 2011. ... Financial Highlights , Total revenues decreased 26.6% year-over-year to ...
Cached Medicine Technology:Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease 2Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease 3Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease 4China Sky One Medical Announces Third Quarter 2011 Results 2China Sky One Medical Announces Third Quarter 2011 Results 3China Sky One Medical Announces Third Quarter 2011 Results 4China Sky One Medical Announces Third Quarter 2011 Results 5China Sky One Medical Announces Third Quarter 2011 Results 6China Sky One Medical Announces Third Quarter 2011 Results 7China Sky One Medical Announces Third Quarter 2011 Results 8China Sky One Medical Announces Third Quarter 2011 Results 9China Sky One Medical Announces Third Quarter 2011 Results 10China Sky One Medical Announces Third Quarter 2011 Results 11China Sky One Medical Announces Third Quarter 2011 Results 12China Sky One Medical Announces Third Quarter 2011 Results 13China Sky One Medical Announces Third Quarter 2011 Results 14China Sky One Medical Announces Third Quarter 2011 Results 15China Sky One Medical Announces Third Quarter 2011 Results 16China Sky One Medical Announces Third Quarter 2011 Results 17China Sky One Medical Announces Third Quarter 2011 Results 18
(Date:8/20/2014)... 2014 Inc. Magazine recently named ... 33rd annual Inc. 500|5000, an exclusive ranking of ... the most comprehensive look at the most important ... as Yelp, Pandora, Timberland, Dell, Domino’s Pizza, LinkedIn, ... exposure as members of the Inc. 500|5000. , ...
(Date:8/20/2014)... 2014 Ticketability.com has Theresa ... fair prices. The well-known medium has been thrilling many ... touring in 19 cities, with tickets becoming available August ... will visit are Albany, Baltimore, Trenton, Erie, Buffalo, Philadelphia, ... Hills and San Diego. The medium’s fans can obtain ...
(Date:8/20/2014)... August 20, 2014 The “Human ... Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid ... Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to ... drivers,restraints, challenges, opportunities, current market trends,and strategies impacting ... estimates and forecasts of the revenue and share ...
(Date:8/20/2014)... 20, 2014 GBK, the luxury lifestyle gift ... Award Nominees and Presenters at the annual GBK Gift Lounge. ... 23rd in Beverly Hills from 11am – 6pm. GBK will ... by DJ Morgan Hildebrand. , As always, GBK will blend ... several charities at the lounge. GO Campaign is a grantmaking ...
(Date:8/20/2014)... What to Do Now for UDI:, ... the Market, **FDAnews Webinar**, Sept. 11, 2014 — 1:30 ... Hospitals and other buyers of devices lose $5 billion ... systems. , Complying with the FDA’s deadlines is important, ... UDI as soon as possible. If devicemakers don’t, ...
Breaking Medicine News(10 mins):Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 2Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 3Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 2Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 4Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 2Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 3Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 4
... MONDAY, Oct. 31 (HealthDay News) -- Construction workers in the ... an increased risk of work-related illness and death, a new ... and found that a construction worker has a 75 percent ... and a 1-in-200 risk of being fatally injured on the ...
... Certain factors unique to professional sports can increase the risk ... staff, a new report suggests. Norovirus is the most ... and causes 21 million cases of illness in the United ... 31 online edition of the journal Clinical Infectious Diseases ...
... Just two extra hours of focused training significantly increased ... polyps , known as adenomas, in the colon, according ... These findings suggest that new methods to educate endoscopists, ... colorectal cancer detection rates and potentially reduce cancer ...
... a 2010 outbreak involving several NBA teams, the ... a professional sports association. Published in Clinical ... ), the study highlights unique circumstances for spreading ... on and off the court. Norovirus ...
... forms of birth control are vastly different from those ... levels of hormones and with different means of delivery ... problems related to women,s pleasure remain. An ... hormonal contraception affect things such as arousal, lubrication and ...
... (October 30 2011)In a technical tour de force, scientists ... the actions of 178 candidate drugs capable of blocking ... including enzymes critical for cancer and other diseases. Additionally, ... available online to the research community. This unique library ...
Cached Medicine News:Health News:'Hard Hats' Still Have High Rates of Injury, Illness: Report 2Health News:Stomach Bug Easily Passed Among Pro Sports Teams: Report 2Health News:Mayo Clinic: Short training course significantly improves detection of precancerous polyps 2Health News:Mayo Clinic: Short training course significantly improves detection of precancerous polyps 3Health News:NBA players not immune to serious illness from norovirus 2Health News:Not your mother's birth control, same troubles 2Health News:First-of-its-kind study creates new tool for targeted cancer drug development 2Health News:First-of-its-kind study creates new tool for targeted cancer drug development 3
... anterior cervical plate system is the lowest ... height includes an integrated lock mechanism, which ... bone screws. Surgeons appreciate the narrow width, ... dissection required. The system also offers easy ...
... been providing excellence in Ambulatory ECG ... of physicians in the diagnosis and ... conditions each year. State-of-the-art equipment and ... the highest standard of customer service ...
... incubator is an extremely compact and ... microplate up to 50C. ,Solo ... higher temperatures up to 65C. Solo ... cost and high performance for varied ...
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
Medicine Products: